Resultados da pesquisa - Nicholas K. Mollanazar, MD

Dupilumab for the treatment of pityriasis lichenoides chronica Por Charissa N. Obeng-Nyarko, MS, Kevin Puerta Durango, BS, BA, Shanelle Jackson, BS, Olaf Rodriguez, MD, Nicholas K. Mollanazar, MD, MBA

Connect to this object online.

Resolution of acquired palmoplantar keratoderma and scurvy after treatment of multivitamin deficiencies Por Corbett T. Berry, MD, PhD, Katarina G. Berry, MS, RD, LDN, James Abbott, MD, Angela J. Jiang, MD, Lukas Ronner, MD, MSc, Nicholas K. Mollanazar, MD, Robin Canada, MD, Douglas J. Pugliese, MD, MPH, Temitayo A. Ogunleye, MD

Connect to this object online.

Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2)Capsule Summary Por Gil Yosipovitch, MD, Brian S. Kim, MD, Shawn G. Kwatra, MD, Nicholas K. Mollanazar, MD, Sonja Ständer, MD, Takahiro Satoh, MD, PhD, Pedro Mendes-Bastos, MD, Tsen-Fang Tsai, MD, Elizabeth Laws, PhD, Michael C. Nivens, PhD, Jennifer Maloney, MD, Genming Shi, PhD, Ashish Bansal, MD, MBA, Ariane Dubost-Brama, MD

Connect to this object online.